Charles Greenberg to Humans
This is a "connection" page, showing publications Charles Greenberg has written about Humans.
Connection Strength
0.630
-
Impact of Benign Hematology Didactic Lectures on In-service Exam in a Hematology-Oncology Fellowship Program: a Cross-sectional Longitudinal Study. J Cancer Educ. 2020 08; 35(4):705-708.
Score: 0.027
-
Importance of platelet activation in the regulation of whole blood coagulation in the presence of a factor V inhibitor. Haemophilia. 2019 Jul; 25(4):e307-e310.
Score: 0.025
-
Analyzing the impact of systems-based hematologist in the healthcare system at an academic medical center. J Thromb Thrombolysis. 2019 Jan; 47(1):109-112.
Score: 0.024
-
Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 Jan; 45(1):130-134.
Score: 0.023
-
Endothelial cell-surface tissue transglutaminase inhibits neutrophil adhesion by binding and releasing nitric oxide. Sci Rep. 2017 11 23; 7(1):16163.
Score: 0.023
-
Inpatient thrombophilia testing: Impact of healthcare system technology and targeted clinician education on changing practice patterns. Vasc Med. 2018 02; 23(1):78-79.
Score: 0.023
-
The role of D-dimer testing in clinical hematology and oncology. Clin Adv Hematol Oncol. 2017 Aug; 15(8):580-583.
Score: 0.022
-
Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes. Amino Acids. 2017 03; 49(3):501-515.
Score: 0.020
-
Histaminylation of fibrinogen by tissue transglutaminase-2 (TGM-2): potential role in modulating inflammation. Amino Acids. 2013 Oct; 45(4):857-64.
Score: 0.017
-
Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013 Jun; 116(6):1210-22.
Score: 0.016
-
TGM2 and implications for human disease: role of alternative splicing. Front Biosci (Landmark Ed). 2013 01 01; 18(2):504-19.
Score: 0.016
-
Numb chin syndrome in acute myeloid leukemia. Am J Med Sci. 2012 Sep; 344(3):237-40.
Score: 0.016
-
Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion. 2013 May; 53(5):1120-31.
Score: 0.016
-
Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation. Protein Sci. 2010 Feb; 19(2):229-35.
Score: 0.013
-
D-dimer antigen: current concepts and future prospects. Blood. 2009 Mar 26; 113(13):2878-87.
Score: 0.012
-
Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem Biol. 2008 Sep 22; 15(9):969-78.
Score: 0.012
-
Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells. FASEB J. 2007 Dec; 21(14):4131-43.
Score: 0.011
-
Roles of transglutaminases in cardiac and vascular diseases. Front Biosci. 2007 Jan 01; 12:2530-45.
Score: 0.011
-
Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer. 2004 Jul 01; 101(1):77-82.
Score: 0.009
-
Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry. 2001 Apr 24; 40(16):4904-10.
Score: 0.007
-
Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis. 2001 Mar; 12(2):85-93.
Score: 0.007
-
Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals. JAMA Netw Open. 2021 01 04; 4(1):e2030435.
Score: 0.007
-
Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation. Blood Coagul Fibrinolysis. 2001 Jan; 12(1):25-31.
Score: 0.007
-
Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center. Thromb Haemost. 2000 Jul; 84(1):93-7.
Score: 0.007
-
Multicenter Evaluation of the Quantra QPlus System in Adult Patients Undergoing Major Surgical Procedures. Anesth Analg. 2020 04; 130(4):899-909.
Score: 0.007
-
Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000 Feb; 18(3):600-8.
Score: 0.007
-
AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019 07; 157(1):34-43.e1.
Score: 0.006
-
Acute kidney injury is associated with low factor XIII in decompensated cirrhosis. Dig Liver Dis. 2019 10; 51(10):1409-1415.
Score: 0.006
-
Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2019 Feb; 47(2):287-291.
Score: 0.006
-
Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem. 1998 Jan 16; 273(3):1776-81.
Score: 0.006
-
Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection. Arch Pathol Lab Med. 1998 Jan; 122(1):31-6.
Score: 0.006
-
Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. J Biol Chem. 1997 Oct 03; 272(40):25149-56.
Score: 0.006
-
Antifibrinolytic drugs and perioperative hemostasis. Am J Hematol. 1997 Sep; 56(1):32-6.
Score: 0.006
-
Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management. Anesthesiology. 1997 Sep; 87(3):667-75.
Score: 0.006
-
Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J Biol Chem. 1997 Jun 27; 272(26):16295-300.
Score: 0.005
-
C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J Biol Chem. 1996 Dec 06; 271(49):31191-5.
Score: 0.005
-
Tissue transglutaminase expression in human breast cancer. Lab Invest. 1996 Nov; 75(5):637-45.
Score: 0.005
-
Practice guidelines and treatment of patients with von Willebrand's disease. Anesthesiology. 1996 Aug; 85(2):441-2.
Score: 0.005
-
Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke. PLoS One. 2015; 10(8):e0134193.
Score: 0.005
-
A rapid method for the diagnosis of von Willebrand's disease subtypes by the clinical laboratory. Arch Pathol Lab Med. 1995 Feb; 119(2):148-52.
Score: 0.005
-
Analysis of the catalytic activity of human factor XIIIa by site-directed mutagenesis. J Biol Chem. 1994 Nov 11; 269(45):28309-13.
Score: 0.005
-
Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem. 1994 Oct; 40(10):1962-9.
Score: 0.005
-
A microtiter plate assay for factor XIII A-chain-fibrin interactions. Anal Biochem. 1994 May 15; 219(1):43-8.
Score: 0.004
-
Purification and characterization of recombinant human coagulant factor XIII A-chains expressed in E. coli. Protein Expr Purif. 1994 Apr; 5(2):125-32.
Score: 0.004
-
Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology. 1994 Mar; 80(3):520-6.
Score: 0.004
-
The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery. Expert Rev Hematol. 2013 Dec; 6(6):677-95.
Score: 0.004
-
Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites. J Biol Chem. 1993 Oct 05; 268(28):21284-92.
Score: 0.004
-
Management of a patient with type IIC von Willebrand's disease during coronary artery bypass graft surgery. Anesthesiology. 1993 Jan; 78(1):195-7.
Score: 0.004
-
Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit. Ann Clin Lab Sci. 2013; 43(4):429-35.
Score: 0.004
-
Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis. Thromb Haemost. 1992 Mar 02; 67(3):292-6.
Score: 0.004
-
Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991 Dec; 5(15):3071-7.
Score: 0.004
-
The use of activated recombinant factor VII in a patient with fulminant hepatic failure requiring placement of an intracranial pressure monitor. Ann Pharmacother. 2011 Nov; 45(11):e60.
Score: 0.004
-
Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures. Ann Pharmacother. 2011 Nov; 45(11):1433-8.
Score: 0.004
-
Limited proteolysis of vitronectin by plasmin destroys heparin binding activity. Thromb Haemost. 1991 Sep 02; 66(3):310-4.
Score: 0.004
-
Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1991 Aug; 34(8):996-1005.
Score: 0.004
-
Vitronectin in the substratum of endothelial cells is cross-linked and phosphorylated. Biochem Biophys Res Commun. 1991 Jan 31; 174(2):465-9.
Score: 0.004
-
Platelets acquire a secretion defect after high-dose chemotherapy. Cancer. 1990 Apr 15; 65(8):1711-6.
Score: 0.003
-
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. Ann Intern Med. 1989 Dec 15; 111(12):1010-22.
Score: 0.003
-
Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review. Am J Hematol. 1989 May; 31(1):53-7.
Score: 0.003
-
Production of a novel anticoagulant by neoplastic plasma cells: report of a case and review of the literature. Am J Med. 1989 May; 86(5):612-6.
Score: 0.003
-
Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen). Biochem J. 1988 Dec 15; 256(3):1013-9.
Score: 0.003
-
b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII. Biochim Biophys Acta. 1988 Sep 08; 966(3):328-35.
Score: 0.003
-
Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets. Thromb Haemost. 1988 Aug 30; 60(1):88-93.
Score: 0.003
-
Monoclonal antibody to fibrin D-dimer (DD-3B6) recognizes an epitope on the gamma-chain of fragment D. Am J Clin Pathol. 1988 May; 89(5):663-6.
Score: 0.003
-
Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII. Arch Biochem Biophys. 1988 Apr; 262(1):142-8.
Score: 0.003
-
The binding of divalent metal ions to platelet factor XIII modulates its proteolysis by trypsin and thrombin. Arch Biochem Biophys. 1988 Feb 15; 261(1):112-21.
Score: 0.003
-
The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen. Am J Clin Pathol. 1987 Oct; 88(4):490-3.
Score: 0.003
-
Transglutaminases: the missing link in nephrogenic systemic fibrosis. Am J Dermatopathol. 2007 Oct; 29(5):433-6.
Score: 0.003
-
Factor XIII binds to the A alpha- and B beta- chains in the D-domain of fibrinogen: an immunoblotting study. Biochem Biophys Res Commun. 1987 Sep 15; 147(2):608-14.
Score: 0.003
-
The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization. Blood. 1987 Sep; 70(3):702-9.
Score: 0.003
-
Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med. 1987 Sep; 83(3):563-6.
Score: 0.003
-
Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib. Blood. 1987 Aug; 70(2):428-31.
Score: 0.003
-
Arterial vimentin is a transglutaminase substrate: a link between vasomotor activity and remodeling? J Vasc Res. 2007; 44(5):339-44.
Score: 0.003
-
Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII. Blood. 1987 Mar; 69(3):867-71.
Score: 0.003
-
Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads. Am J Clin Pathol. 1987 Jan; 87(1):94-100.
Score: 0.003
-
Thrombin binding to fibrin is necessary for fibrin polymers to enhance factor XIIIa formation. Semin Thromb Hemost. 1986 Jul; 12(3):226-7.
Score: 0.003
-
Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease. Blood. 1986 Jul; 68(1):317-9.
Score: 0.003
-
Regulation of thrombin cleavage of plasma factor XIII bound to fibrin. Ann N Y Acad Sci. 1986; 485:140-3.
Score: 0.002
-
Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery. J Thorac Cardiovasc Surg. 2005 Dec; 130(6):1567-72.
Score: 0.002
-
Regulation of plasma factor XIII binding to fibrin in vitro. Blood. 1985 Nov; 66(5):1028-34.
Score: 0.002
-
The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation. Blood. 1985 Aug; 66(2):466-9.
Score: 0.002
-
Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J Clin Invest. 1985 May; 75(5):1463-70.
Score: 0.002
-
Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity. Cancer Res. 2005 Feb 15; 65(4):1369-75.
Score: 0.002
-
Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline. Anal Biochem. 1985 Jan; 144(1):165-71.
Score: 0.002
-
Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. J Biol Chem. 1984 Dec 10; 259(23):14721-7.
Score: 0.002
-
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002 Aug 01; 100(3):743-54.
Score: 0.002
-
Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res. 2002 Jan; 20(1):76-82.
Score: 0.002
-
Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. Lab Invest. 2001 Jan; 81(1):83-93.
Score: 0.002
-
Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery. J Clin Anesth. 2000 Mar; 12(2):136-41.
Score: 0.002
-
The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg. 1997 Dec; 85(6):1221-6.
Score: 0.001
-
Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to monitor anticoagulation. Anesthesiology. 1997 Oct; 87(4):990-2.
Score: 0.001
-
Assessments of thrombogenicity by three in vitro techniques. Student Research Award in the Undergraduate, Master Candidate, or Health Science Degree Candidate Category, 21st annual meeting of the Society for Biomaterials, San Francisco, CA, March 18-22, 1995. J Biomed Mater Res. 1995 Sep; 29(9):1039-45.
Score: 0.001
-
Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet. 1994 Apr; 6(4):409-14.
Score: 0.001
-
High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathways. Mol Pharmacol. 1993 Jan; 43(1):37-44.
Score: 0.001
-
Exploration of rapid bedside monitoring of coagulation and fibrinolysis parameters during thrombolytic therapy. Blood Coagul Fibrinolysis. 1992 Feb; 3(1):47-54.
Score: 0.001
-
Epidural anesthesia and analgesia: implications for perioperative coagulability. Anesth Analg. 1991 Dec; 73(6):683-5.
Score: 0.001
-
"Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass. Anesthesiology. 1990 Sep; 73(3):562-5.
Score: 0.001
-
Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury. Cancer. 1990 Aug 01; 66(3):515-21.
Score: 0.001
-
Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders. Blood. 1990 Apr 15; 75(8):1699-704.
Score: 0.001
-
Superficial migratory thrombophlebitis and the lupus anticoagulant. Int J Dermatol. 1990 Apr; 29(3):190-2.
Score: 0.001
-
Preoperative assessment of fragment D-dimer as a predictor of postoperative venous thrombosis. Am J Obstet Gynecol. 1990 Mar; 162(3):772-5.
Score: 0.001
-
Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets. Biochem Biophys Res Commun. 1989 Dec 15; 165(2):708-14.
Score: 0.001
-
Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding. J Biol Chem. 1989 Nov 05; 264(31):18440-4.
Score: 0.001
-
Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia. Obstet Gynecol. 1989 Mar; 73(3 Pt 1):435-40.
Score: 0.001
-
Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function. Cancer Res. 1988 Oct 01; 48(19):5604-9.
Score: 0.001
-
Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood. 1988 Jul; 72(1):128-33.
Score: 0.001
-
Procainamide-induced lupus anticoagulants and thrombosis. South Med J. 1988 Feb; 81(2):262-4.
Score: 0.001
-
Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. J Biol Chem. 1987 Oct 05; 262(28):13620-6.
Score: 0.001
-
Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery. Ann Thorac Surg. 1987 Jun; 43(6):617-21.
Score: 0.001
-
Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg. 1986 Nov; 4(5):522-8.
Score: 0.001
-
Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood. 1983 Jun; 61(6):1155-62.
Score: 0.001